Cas9 Cell Lines
Learn MoreLuciferase Stable Cell Lines are genetically engineered cells that stably express the luciferase enzyme, an enzyme that produces bioluminescence in the presence of its substrate, luciferin. These cell lines are designed to provide consistent and long-term luminescent signal production, making them invaluable tools in various research applications. The stable integration of the luciferase gene ensures that the bioluminescent signal remains stable over time, allowing for reliable and reproducible results in experiments. Luciferase Stable Cell Lines are widely used in gene expression studies, drug screening, and real-time monitoring of cellular processes.
Luciferase Stable Cell Lines are extensively applied in high-throughput drug screening, where they enable rapid and sensitive detection of cellular responses to potential drug candidates. The bioluminescent signal produced by these cells provides a quantifiable and non-invasive method to monitor gene expression, protein-protein interactions, and signal transduction pathways in real time. In cancer research, they are used to track tumor growth and metastasis in vivo by measuring luciferase activity, providing insights into the effectiveness of anti-cancer therapies. Additionally, these cell lines are employed in various functional assays, such as promoter activity studies, where the luminescent output serves as a reporter for the activation or repression of specific genetic elements, facilitating the analysis of regulatory mechanisms.
Establishment of an Evaluation Method for siRNA Delivery by Using HeLa-luc Cells or CHO-luc Cells Carrying the Luciferase Reporter Gene(C Lai, et al.,2006)
We should use inducers to express luciferase in these HeLa-luc cells and CHO-luc cells. We considered that it is better to choose a shorter incubation time with inducers and lower inducer concentrations, because the inducers were shown to be cytotoxic for these mammalian cells. And, we considered that the number of seeded cells should be set to achieved was 90—95% confluent in luciferase assay. Thus, we optimized the inducing conditions for HeLa-luc cells and CHO-luc cells accordingly. In the case of HeLa-luc cells, when the number of seeded cells was 6103 cells/well, about 95% confluent was achieved in luciferase assay. For the inducer concentrations of 5 ng/ml of PMA and 0.25 mM of A23187, luciferase was expressed at low level. However, when the inducer concentrations were 10 ng/ml of PMA and 0.5 mM of A23187, luciferase was expressed at high level. Luciferase was expressed at high level in 6 h incubations with inducers, which was the shortest time condition of all (all of the conditions are indicated by the asterisk in Fig. 4A). In addition, when the HeLa-luc cells were incubated for 24 h with inducers, their shapes were changed. In the case of CHO-luc cells, when the number of seeded cells was 8103 cells/well, about 95% confluent was achieved in luciferase assay. For the inducer concentration of 1 mM of Dex, which was the lowest concentration of all, luciferase was expressed at high level. The CHO-luc cells were less sensitive than HeLa-luc cells, so we considered that favorable incubation time was 7 h, in which the highest luciferase activity in the condition of 8103 cells/well for the number of seeded cells and 1 mM of Dex (all of the conditions are indicated by the asterisk in Fig. 4B). Furthermore, in the case of HeLa-luc cells, cellular cytotoxicity appeared after 24 h of incubation with more than 0.4 ml of Lipofectamine2000/well. At incubations of 48 h, however, cellular cytotoxicity appeared with more than 0.05 ml Lipofectamine2000/well (Fig. 5). It was considered that total incubation time with Lipofectamine2000 had to be 24 h for HeLa-luc cells. We outlined the optimised experimental conditions for siRNA transfection in HeLa-luc cells and CHO-luc cells in Chart 2.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.